Back to search

University of British Columbia

Neuropathic pain and the multiple sclerosis prodrome : a population-based matched cohort study

Abstract

dc:description

Introduction: There is evidence of a prodromal phase in multiple sclerosis (MS), which may involve increased health care visits for pain-related issues in the years preceding MS onset. Over 50% of MS patients experience neuropathic pain, with gabapentinoids and/or other anticonvulsants among the first-line treatments for neuropathic pain. This study’s objective was to estimate the number of MS cases vs matched controls who filled at prescriptions gabapentinoids with and without other anticonvulsants (as use of both may suggest epilepsy treatment). Methods: This population-based matched cohort study used health administrative data from British Columbia, from 1996 to 2013. MS cases were defined based on a previously validated criteria and their first demyelinating-disease claim was defined as the index date. Up to 5 controls were matched to cases by sex, age, calendar-year, and geographical location at index date. In the five years before the index date, we compared cases and controls regarding use of anticonvulsants and gabapentinoids not combined with anticonvulsants Age-and-sex adjusted odds ratios (aOR) and 95% confidence intervals (CIs) were estimated using logistic regression. Results: The cohort comprised 4,862 MS cases and 22,669 controls; 72% were female. In the 5 years before the index date, 992 (20%) cases and 1,600 (7.1%) controls filled at least one prescription for any anticonvulsant, while 371 (7.6%) cases and 473 (2.1%) controls filled at least one prescription for gabapentinoids not combined with any other anticonvulsants. The odds of a filled prescription were higher for cases than controls for any anticonvulsants (aOR = 3.40, 95% CI: 3.12, 3.71), and for gabapentinoids without other anticonvulsants (aOR = 4.05, 95% CI: 3.52, 4.66). Conclusion: Neuropathic pain-related medication use was more common for MS patients in the five years before MS onset versus matched controls, suggesting that neuropathic pain may be part of the MS prodrome.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Pharmacology and Therapeutics
Grantor dc:publisher
University of British Columbia
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Bergeron-Vitez, Himali
Contributors dc:contributor
  • Kramer, John L. K.
  • Tremlett, Helen

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/85529

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Bergeron-Vitez, Himali. Neuropathic pain and the multiple sclerosis prodrome : a population-based matched cohort study. master's thesis, University of British Columbia, 2023. http://hdl.handle.net/2429/85529